Quantcast

Latest Eisai Stories

2014-11-07 12:26:14

WASHINGTON, Nov. 7, 2014 /PRNewswire-USNewswire/ -- The National Pharmaceutical Council (NPC) today announced that David J.

2014-11-04 16:28:36

Focus on the Completion of Phase 3 Clinical Trials and Commercial Preparations for Telotristat Etiprate in Carcinoid Syndrome THE WOODLANDS, Texas, Nov.

2014-11-03 08:30:12

-- Trial Met Primary Efficacy Endpoint with Statistical Significance After 12 Weeks of Treatment -- WOODCLIFF LAKE, N.J. and SAN DIEGO, Nov. 3, 2014 /PRNewswire/ -- Eisai Inc.

2014-10-30 04:21:03

TAIPEI, Oct. 30, 2014 /PRNewswire/ -- TWi Pharmaceuticals, Inc.

2014-10-28 20:23:45

-- Trial Met Primary Safety Objective After 12 Weeks of Treatment -- WOODCLIFF LAKE, N.J. and SAN DIEGO, Oct. 28, 2014 /PRNewswire/ -- Eisai Inc. and Arena Pharmaceuticals, Inc.

2014-10-24 08:25:17

Winner to be Featured in Third Book of Epilepsy Education Comic Book Series WOODCLIFF LAKE, N.J., Oct.

2014-10-19 23:00:34

RnRMarketResearch.com adds “Partial Seizure – Pipeline Review, H2 2014” to its store.

2014-10-14 16:28:33

WOODCLIFF LAKE, N.J., Oct. 14, 2014 /PRNewswire/ -- Eisai Inc. announced today that the U.S.

2014-10-13 12:26:32

Recognizing unique patient needs on Metastatic Breast Cancer Awareness Day, mbcInfoCenter.com offers important metastatic breast cancer resources in one convenient place WOODCLIFF LAKE, N.J.,

2014-10-13 08:26:39

WOODCLIFF LAKE, N.J. and SAN DIEGO, Oct. 13, 2014 /PRNewswire/ -- Eisai Inc. and Arena Pharmaceuticals, Inc.